Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery … DY Usta, B Timur, ZS Teksin European Journal of Pharmaceutical Sciences 174, 106159, 2022 | 39 | 2022 |
Development and pharmacokinetic evaluation of Neusilin® US2-based S-SNEDDS tablets for bosentan: Fasted and fed states bioavailability, IVIS® real-time biodistribution, and ex … DY Usta, S Olgac, B Timur, ZS Teksin International Journal of Pharmaceutics 643, 123219, 2023 | 8 | 2023 |
Investigation of the effect of colloidal structures formed during lipolysis of lipid-based formulation on exemestane permeability using the in vitro lipolysis-permeation model B Timur, DY Usta, ZS Teksin Journal of Drug Delivery Science and Technology 77, 103797, 2022 | 7 | 2022 |
Enhancement of in vitro dissolution, in vitro lipolysis, ex-vivo permeability, and fasted and fed state bioavailability of Bosentan-solid SNEDDS: New oral drug delivery system … D Yılmaz Usta, S Olğaç, B Timur, Z Teksin | 2 | 2021 |
In vitro, ex vivo, and in vivo evaluation of Bosentan loaded self nanoemulsifying drug delivery system D Yilmaz Usta, B Timur, ZS Teksin EUFEPS Annual Meeting, 7-9, 2021 | 2 | 2021 |
Bitkisel İlaçların Farmakokinetik-Biyoyararlanım Değerlendirmeleri ve Ruhsat Aşamaları: Geleneksel Derleme. B TİMUR, ZŞ TEKSİN Journal of Literature Pharmacy Sciences 11 (1), 2022 | | 2022 |
Solid-State Characterization Studies of Bosentan-Loaded Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) Comprising of Neusilin® US2 D Yılmaz Usta, S Olgac, Z Teksin, T İnceçayır, B Timur GAZI MEDICAL JOURNAL 31, 498-509, 2020 | | 2020 |
The Development of Exemestane-loaded Self-nanoemulsifying Drug Delivery System B Timur, D Yılmaz Usta, Z Teksin Colloids and Surfaces B: Biointerfaces 167, 82-92, 2018 | | 2018 |
Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery … UD YILMAZ, B TİMUR, ZŞ TEKSİN | | |
Development and pharmacokinetic evaluation of Neusilin® US2-based S-SNEDDS tablets for bosentan: Fasted and fed states bioavailability, IVIS® real-time biodistribution, and ex … UD YILMAZ, S OLĞAÇ, B TİMUR, ZŞ TEKSİN | | |
Evaluation of EXE-loaded SNEDDS using simultaneous lipolysis/ex-vivo permeability and lipolysis/in situ single-pass intestinal perfusion method B Timur, S Olğaç, D Yılmaz Usta, M Demirel, Z Teksin | | |
DEVELOPMENT OF IN VITRO LIPOLYSIS-PERMEATION METHOD TO ESTIMATE ORAL ABSORPTION OF EXEMESTANE-LOADED LIPID-BASED FORMULATION B Timur, D Yılmaz Usta, Z Teksin | | |
Assessment of in vitro digestion for exemestane-loaded lipid-based formulations B Timur, D Yılmaz Usta, Z Teksin | | |
Evaluation of Fasted and Fed State Intestinal In Vitro Lipolysis Test for Bosentan Loaded Lipid-Based Drug Delivery Systems B TİMUR, S OLĞAÇ, D YILMAZ USTA, Z TEKSİN | | |
Evaluation of in vitro-in vivo relationship: Bosentan-loaded lipid based formulation versus commercial product B Timur, D YILMAZ USTA, Z TEKSİN | | |
Comparison of In Vitro Lipolysis of Bosentan-Loaded Lipid-Based Formulations in Fasted State Biorelevant Media B Timur, D Yılmaz Usta, Z Teksin | | |
Assessment The Correlation Between In Vitro Dissolution and In Vitro Intestinal Lipolysis Data for Bosentan Loaded Lipid-Based Formulations B TİMUR, D YILMAZ USTA, Z TEKSİN | | |
IN VITRO CHARACTERIZATION OF EXEMESTANE-LOADED SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM CONTAINING MEDIUM CHAIN MONO AND DIGLYCERIDES B Timur, D Yılmaz Usta, Z Teksin | | |